Loading

Press Releases

Press Releases

  1. Merus N.V. Signs Commercial Multi-Product License for ProBioGen’s GlymaxX® ADCC Enhancement Technology

    PDF Download

  2. ProBioGen Will License GlymaxX® to Thermo Fisher Scientific for Use in Developing Allergy Diagnostics

    PDF Download

  3. ProBioGen And Eucodis Sign Agreement to Commercialize C-LiNK, A Novel Antibody Drug Conjugation Technology

    PDF Download

  4. ProBioGen in Biosimilar Deal with Bio Farma Indonesia

  5. Zymeworks Contracts ProBioGen for Bi-specific GlymaxX® Antibody Cell Line Development

    PDF Download

  6. ProBioGen Inks Another Commercial GlymaxX® License and Contract Manufacturing Service Agreement on Immuno-Oncology Antibody

    PDF Download

  7. Anti-Ebola MVA Vaccine Produced on ProBioGen’s Avian AGE1.CR® Cell Line Platform in Clinical Trials

    PDF Download